Amp Capital Investors LTD Alkermes Plc. Transaction History

Amp Capital Investors LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$13.06 - $21.24 $522,465 - $849,706	-40,005 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$17.29 - $21.74 $58,647 - $73,742	-3,392 Reduced 7.82%	40,005 $805,000
Q3 2019 Nov 13, 2019	SELL	$19.51 - $24.28 $1.27 Million - $1.59 Million	-65,282 Reduced 60.07%	43,397 $853,000
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $478,802 - $832,496	-22,301 Reduced 17.03%	108,679 $2.41 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $2.46 Million - $3.15 Million	86,450 Added 194.14%	130,980 $4.67 Million
Q3 2018 Nov 13, 2018	SELL	$38.6 - $46.12 $12,159 - $14,527	-315 Reduced 0.7%	44,530 $1.93 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $477,129 - $598,614	-8,900 Reduced 16.56%	44,845 $2.66 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $260,842 - $288,911	5,306 Added 10.95%	53,745 $2.73 Million
Q2 2017 Aug 14, 2017	BUY	N/A	48,439	48,439 $2.81 Million

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.